Key result
Meril Myval percutaneous pulmonary valve replacement succeeds in a patient with severe RV-PA conduit dysfunction.
Why the study?
Transcatheter pulmonary valve implantation is established for treating right ventricular outflow tract dysfunction, but experience with Indian made valves is not reported.
Case Report (n=1)
This case report provides the first evidence of successful transcatheter pulmonary valve implantation using the Meril Myval valve for RV-PA conduit dysfunction.
Answers are grounded in this paper and cite their sources.
First successful case supports feasibility in congenital heart disease; leaves open durability, safety, and broader applicability.
Transcatheter Pulmonary Valve Implantation has become the treatment of choice in most congenital heart disease patients with degeneration and dysfunction of a previous Right ventricular outflow tract repair. It is less invasive, with a high procedural success rate. Efficacy and safety have been demonstrated for the Medtronic Melody® valve (Medtronic Inc., MN, USA) and Edwards SAPIEN™ valve (Edwards Lifesciences) in pulmonary position. We report the first successful percutaneous pulmonary valve replacement with an Indian made valve Meril Myval™ in a symptomatic patient who had severe Right ventricle-pulmonary artery conduit dysfunction post Tetralogy of Fallot intracardiac repair.
No takes yet. Share an insight, caveat, or question.
Sivaprakasam et al. (2020) conducted a case report in Severe Right ventricle-pulmonary artery conduit dysfunction post Tetralogy of Fallot intracardiac repair (n=1). Percutaneous pulmonary valve replacement with Meril Myval™ valve was evaluated on Procedural success. Percutaneous pulmonary valve replacement using the Indian-made Meril Myval™ valve was successfully performed in a symptomatic patient with severe RV-PA conduit dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: